Company / SG&A per Share
Caris Life Sciences, Inc. SG&A per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$6.16
FY2025
5-year range
$4.27 / $6.16
FY2023-FY2025
Trend
+29.1%
vs FY2024
Sector context
#72 of 157
Health Care
What the data says
At $6.16, Caris Life Sciences, Inc.'s sg&a per share ranks #86 of 157 in the Health Care sector. Increased from $4.27 to $6.16 over the past 2 years.
Based on SEC 10-K filings.
6.16 in FY2025.
Increased from $4.27 to $6.16 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#86 of 157 in Health CareTop 54% of 157This company $6.16 Sector average $11348.84
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 29.1% year-over-year.
- Ranks #72 out of 157 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.16 | +29.1% |
| FY2024 | $4.77 | +11.9% |
| FY2023 | $4.27 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026